Market Overview:
The global leptin receptor market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and metabolic disorders, rising awareness about the benefits of leptin receptor therapies, and increasing R&D investments by pharmaceutical companies. The global leptin receptor market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into memtin, metreleptin, CV-08 ( metreleptin ), XL-100 ( metreleptin ), and others. On the basis of application, the market is segmented into metabolic disorder , Alzheimer's disease , obesity , and others . The North America region dominates this market followed by Europe .
Product Definition:
Leptin receptor is a protein that is found on the surface of cells. It binds to leptin, a hormone that is produced by fat cells. When leptin binds to its receptor, it causes the cell to respond in some way. Leptin receptor may play a role in regulating food intake and body weight.
Memtin:
Memtin, also known as LYNPARZA is a promising drug candidate currently in phase II clinical trials for the treatment of obesity. Memtin has completed Phase I study and is now in Phase II clinical trial. The primary endpoint of this study includes assessment of safety and efficacy based on body weight loss at 6 months and 12 months respectively.
Metreleptin:
Metreleptin is a peptide hormone, which regulates the body fat mass. It is produced by white adipose tissue and released into the blood stream. The main function of this peptide is to signal to the brain that there’s enough energy in the bloodstream and it should stop feeding habits for now.
Application Insights:
Obesity held the largest revenue share in 2017. Leptin plays a major role in controlling food intake and energy expenditure. An increase in circulating leptin levels results in increased food intake and weight gain, which eventually leads to obesity. The other major application of this drug is related to metabolic disorders, such as type 2 diabetes mellitus (T2DM). According to the International Diabetes Federation (IDF), currently more than 400 million people are suffering from T2DM across the globe, with approximately 90% of them being overweight or obese. Thus, increasing incidence rates of T2DM will boost market growth during the forecast period.
The others segment includes applications such as Alzheimer's disease and cardiovascular diseases; both are expected to witness significant growth during this forecast period due to rising prevalence rates globally coupled with increasing usage patterns for treatment procedures involving these diseases stateside U S A .
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of obesity and related disorders, such as diabetes and cardiovascular diseases. According to a study published by National Center for Health Statistics (NCHS), in U.S., from 2015-2016, around 29% of adults were suffering from obesity while 13% of children were obese at that time.
Growth Factors:
- Increasing obesity rates across the globe will drive demand for leptin receptor therapies and products.
- Growing awareness of the health benefits associated with leptin receptor therapies will spur demand over the forecast period.
- The increasing prevalence of diabetes and other metabolic disorders will create a high unmet need for leptin receptor-based therapeutics, which is expected to result in robust market growth.
- Rising R&D investment by pharmaceutical companies is anticipated to lead to the development of novel leptin receptor-based drugs, fueling market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Leptin Receptor Market Research Report
By Type
Memtin, Metreleptin, CV-08, XL-100, Others
By Application
Metabolic Disorder, Alzheimer's Disease, Obesity, Others
By Companies
ConSynance Therapeutics Inc, Jyant Technologies Inc, NeuroNano Pharma Inc, Neurotez Inc, Novelion Therapeutics Inc, XL-protein GmbH, ConSynance Therapeutics Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Leptin Receptor Market Report Segments:
The global Leptin Receptor market is segmented on the basis of:
Types
Memtin, Metreleptin, CV-08, XL-100, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Metabolic Disorder, Alzheimer's Disease, Obesity, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ConSynance Therapeutics Inc
- Jyant Technologies Inc
- NeuroNano Pharma Inc
- Neurotez Inc
- Novelion Therapeutics Inc
- XL-protein GmbH
- ConSynance Therapeutics Inc
Highlights of The Leptin Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Memtin
- Metreleptin
- CV-08
- XL-100
- Others
- By Application:
- Metabolic Disorder
- Alzheimer's Disease
- Obesity
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leptin Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Leptin receptor is a protein that helps to control the amount of food we eat.
Some of the major players in the leptin receptor market are ConSynance Therapeutics Inc, Jyant Technologies Inc, NeuroNano Pharma Inc, Neurotez Inc, Novelion Therapeutics Inc, XL-protein GmbH, ConSynance Therapeutics Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leptin Receptor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leptin Receptor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leptin Receptor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leptin Receptor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leptin Receptor Market Size & Forecast, 2020-2028
4.5.1 Leptin Receptor Market Size and Y-o-Y Growth
4.5.2 Leptin Receptor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Memtin
5.2.2 Metreleptin
5.2.3 CV-08
5.2.4 XL-100
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Metabolic Disorder
6.2.2 Alzheimer's Disease
6.2.3 Obesity
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leptin Receptor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leptin Receptor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Memtin
9.6.2 Metreleptin
9.6.3 CV-08
9.6.4 XL-100
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Metabolic Disorder
9.10.2 Alzheimer's Disease
9.10.3 Obesity
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Memtin
10.6.2 Metreleptin
10.6.3 CV-08
10.6.4 XL-100
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Metabolic Disorder
10.10.2 Alzheimer's Disease
10.10.3 Obesity
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Memtin
11.6.2 Metreleptin
11.6.3 CV-08
11.6.4 XL-100
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Metabolic Disorder
11.10.2 Alzheimer's Disease
11.10.3 Obesity
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Memtin
12.6.2 Metreleptin
12.6.3 CV-08
12.6.4 XL-100
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Metabolic Disorder
12.10.2 Alzheimer's Disease
12.10.3 Obesity
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Memtin
13.6.2 Metreleptin
13.6.3 CV-08
13.6.4 XL-100
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Metabolic Disorder
13.10.2 Alzheimer's Disease
13.10.3 Obesity
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leptin Receptor Market: Competitive Dashboard
14.2 Global Leptin Receptor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ConSynance Therapeutics Inc
14.3.2 Jyant Technologies Inc
14.3.3 NeuroNano Pharma Inc
14.3.4 Neurotez Inc
14.3.5 Novelion Therapeutics Inc
14.3.6 XL-protein GmbH
14.3.7 ConSynance Therapeutics Inc
